Demidova, T. Y., Krasil’nikova, E. I., Vorob’ev, S. V., Morugova, T. V., & Adasheva, T. V. (2021). The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: Results of a multicenter double blind placebo controlled randomized clinical trial. "Consilium Medicum" Publishing house.
Cita Chicago Style (17a ed.)Demidova, Tatiana Y., Elena I. Krasil’nikova, Sergey V. Vorob’ev, Tatiana V. Morugova, y Tatiana V. Adasheva. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.
Cita MLA (8a ed.)Demidova, Tatiana Y., et al. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.